In contrast, increased levels of Nlrp3 and Casp1 were previously shown in amyloid-beta (Aβ) treated BV2 microglia cells, and in the cortex and hippocampal tissues of the APP/PS1 AD mouse model. This evidence concerns the gene NLRP3 and Alzheimer disease.